Archive for January, 2009

Product Management Today - Muscle relaxant approved

Thursday, January 8th, 2009

The FDA announced final approval of Detroit-based Caraco Pharmaceutical Laboratories’ ANDA for baclofen tablets, 10 and 20 mg. The drug is a muscle relaxant and antispastic, and the manufacturer claims it can alleviate signs and symptoms of spasticity (including flexor spasms and concomitant pain, clonus, and muscular rigidity) resulting from multiple sclerosis.

Related Results

Patient management of cerebral origin spasticity with intrathecal…

Exceptional Parent, The - Oral baclofen

Tuesday, January 6th, 2009

CATEGORY: CEREBRAL PALSY
Anonymous has a 14-year-old son with spastic quadriplegia cerebral palsy and wants to hear from families who have tried oral baclofen.

Related Results

Patient management of cerebral origin …